Pharmacokinetics of metronidazole in patients undergoing peritoneal dialysis.
AUTOR(ES)
Cassey, J G
RESUMO
After a single 500-mg intravenous dose of metronidazole, plasma and dialysate levels were measured over a 7.5-h period in five patients undergoing peritoneal dialysis for terminal renal failure. Approximately 10% of this dose was removed by dialysis during that period, and therapeutic levels were maintained in plasma. No routine adjustment in the dosage of metronidazole appears necessary in patients undergoing peritoneal dialysis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185414Documentos Relacionados
- Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis.
- Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.
- Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.
- Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
- Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis.
